The problem of sepsis and the new SeptiCyte® approach to diagnostics

These series of interviews with U.S. clinicians recognized for their work in sepsis identification and treatment lay out the current problem they face day-to-day. A sepsis survivor explains his ordeal. And the Immunexpress team explains how SeptiCyte® will be able to tackle the problem earlier and faster.

Immunexpress CEO Roslyn Brandon featured in the University of Queensland’s Create Change Campaign